These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 16991138)

  • 1. Association of olfactory dysfunction with incidental Lewy bodies.
    Ross GW; Abbott RD; Petrovitch H; Tanner CM; Davis DG; Nelson J; Markesbery WR; Hardman J; Masaki K; Launer L; White LR
    Mov Disord; 2006 Dec; 21(12):2062-7. PubMed ID: 16991138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bowel movement frequency in late-life and incidental Lewy bodies.
    Abbott RD; Ross GW; Petrovitch H; Tanner CM; Davis DG; Masaki KH; Launer LJ; Curb JD; White LR
    Mov Disord; 2007 Aug; 22(11):1581-6. PubMed ID: 17523195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewy bodies and olfactory dysfunction in old age.
    Wilson RS; Yu L; Schneider JA; Arnold SE; Buchman AS; Bennett DA
    Chem Senses; 2011 May; 36(4):367-73. PubMed ID: 21257733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olfactory system pathology as a model of Lewy neurodegenerative disease.
    Duda JE
    J Neurol Sci; 2010 Feb; 289(1-2):49-54. PubMed ID: 19783257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neocortical Lewy bodies are associated with impaired odor identification in community-dwelling elders without clinical PD.
    Nag S; Yu L; VanderHorst VG; Schneider JA; Bennett DA; Buchman AS; Wilson RS
    J Neurol; 2019 Dec; 266(12):3108-3118. PubMed ID: 31535271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anterior olfactory nucleus in Parkinson's disease.
    Pearce RK; Hawkes CH; Daniel SE
    Mov Disord; 1995 May; 10(3):283-7. PubMed ID: 7651444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
    McShane RH; Nagy Z; Esiri MM; King E; Joachim C; Sullivan N; Smith AD
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):739-43. PubMed ID: 11385006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of olfactory dysfunction with risk for future Parkinson's disease.
    Ross GW; Petrovitch H; Abbott RD; Tanner CM; Popper J; Masaki K; Launer L; White LR
    Ann Neurol; 2008 Feb; 63(2):167-73. PubMed ID: 18067173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical localization of apoptosome-related proteins in Lewy bodies in Parkinson's disease and dementia with Lewy bodies.
    Kawamoto Y; Ito H; Ayaki T; Takahashi R
    Brain Res; 2014 Jul; 1571():39-48. PubMed ID: 24835407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mercury is present in neurons and oligodendrocytes in regions of the brain affected by Parkinson's disease and co-localises with Lewy bodies.
    Pamphlett R; Bishop DP
    PLoS One; 2022; 17(1):e0262464. PubMed ID: 35015796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD.
    Mahlknecht P; Iranzo A; Högl B; Frauscher B; Müller C; Santamaría J; Tolosa E; Serradell M; Mitterling T; Gschliesser V; Goebel G; Brugger F; Scherfler C; Poewe W; Seppi K;
    Neurology; 2015 Feb; 84(7):654-8. PubMed ID: 25609758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Lewy Bodies With Age-Related Clinical Characteristics in Black and White Decedents.
    Nag S; Barnes LL; Yu L; Buchman AS; Bennett DA; Schneider JA; Wilson RS
    Neurology; 2021 Aug; 97(8):e825-e835. PubMed ID: 34088871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders.
    Beach TG; White CL; Hladik CL; Sabbagh MN; Connor DJ; Shill HA; Sue LI; Sasse J; Bachalakuri J; Henry-Watson J; Akiyama H; Adler CH;
    Acta Neuropathol; 2009 Feb; 117(2):169-74. PubMed ID: 18982334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional imaging of the cerebral olfactory system in patients with Parkinson's disease.
    Westermann B; Wattendorf E; Schwerdtfeger U; Husner A; Fuhr P; Gratzl O; Hummel T; Bilecen D; Welge-Lüssen A
    J Neurol Neurosurg Psychiatry; 2008 Jan; 79(1):19-24. PubMed ID: 17519323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.
    Iranzo A; Tolosa E; Gelpi E; Molinuevo JL; Valldeoriola F; Serradell M; Sanchez-Valle R; Vilaseca I; Lomeña F; Vilas D; Lladó A; Gaig C; Santamaria J
    Lancet Neurol; 2013 May; 12(5):443-53. PubMed ID: 23562390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa.
    Funabe S; Takao M; Saito Y; Hatsuta H; Sugiyama M; Ito S; Kanemaru K; Sawabe M; Arai T; Mochizuki H; Hattori N; Murayama S
    Neuropathology; 2013 Feb; 33(1):47-58. PubMed ID: 22672612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.